Arcutis Biotherapeutics Inc’s filing revealed that its Director Welgus Howard G. unloaded Company’s shares for reported $0.13 million on Jul 01 ’25. In the deal valued at $13.84 per share,9,208 shares were sold. As a result of this transaction, Welgus Howard G. now holds 100,206 shares worth roughly $1.34 million.
Then, Welgus Howard G. bought 9,208 shares, generating $127,431 in total proceeds.
Before that, Welgus Howard G. sold 10,139 shares. Arcutis Biotherapeutics Inc shares valued at $135,574 were divested by the Director at a price of $13.37 per share. As a result of the transaction, Welgus Howard G. now holds 109,414 shares, worth roughly $1.47 million.
H.C. Wainwright initiated its Arcutis Biotherapeutics Inc [ARQT] rating to a Buy in a research note published on December 30, 2024; the price target was $19. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. Mizuho also remained covering ARQT and has increased its forecast on January 03, 2024 with a “Buy” recommendation from previously “Neutral” rating. Mizuho revised its rating on October 26, 2023. It rated ARQT as “a Neutral” which previously was an “a Buy”.
Price Performance Review of ARQT
On Monday, Arcutis Biotherapeutics Inc [NASDAQ:ARQT] saw its stock fall -3.11% to $13.39. Over the last five days, the stock has lost -2.55%. Arcutis Biotherapeutics Inc shares have risen nearly 43.98% since the year began. Nevertheless, the stocks have fallen -3.88% over the past one year. While a 52-week high of $17.75 was reached on 03/25/25, a 52-week low of $7.86 was recorded on 02/11/25.
Levels Of Support And Resistance For ARQT Stock
The 24-hour chart illustrates a support level at 13.03, which if violated will result in even more drops to 12.67. On the upside, there is a resistance level at 13.78. A further resistance level may holdings at 14.16.
How much short interest is there in Arcutis Biotherapeutics Inc?
A steep rise in short interest was recorded in Arcutis Biotherapeutics Inc stocks on 2025-06-13, growing by 2.61 million shares to a total of 18.64 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 16.04 million shares. There was a rise of 13.99%, which implies that there is a positive sentiment for the stock.
